Management of Markedly Elevated Vitamin D Level (123 ng/mL) in a 12-Year-Old Male
Immediately discontinue all vitamin D supplementation and assess for vitamin D toxicity by checking serum calcium, PTH, and urinary calcium/creatinine ratio. 1
Initial Assessment
Your patient's vitamin D level of 123 ng/mL (approximately 308 nmol/L) exceeds the recommended upper limit of 250 nmol/L (100 ng/mL) defined by consensus guidelines, placing him at risk for toxicity 1. However, true vitamin D toxicity requires both elevated 25OHD ≥250 nmol/L AND hypercalcemia with hypercalciuria and suppressed PTH 1.
Critical Laboratory Evaluation Needed:
- Serum calcium (ionized and total)
- Serum PTH (should be suppressed if toxic)
- Serum phosphorus
- Urinary calcium/creatinine ratio (spot urine)
- Serum creatinine/BUN (assess renal function)
- Serum alkaline phosphatase
Risk Stratification Based on Calcium Status
If Hypercalcemic (Vitamin D Toxicity Confirmed):
This represents true vitamin D intoxication requiring aggressive management 1:
- Stop all vitamin D immediately - including multivitamins and fortified foods
- Initiate aggressive IV hydration with normal saline 2, 3
- Add furosemide to enhance calciuresis 3
- Start prednisone 1-2 mg/kg/day (reduces intestinal calcium absorption and vitamin D effects) 2, 3
- Order renal ultrasound to evaluate for nephrocalcinosis or nephrolithiasis 1, 3
- Monitor calcium levels closely - initially daily, then every 2-3 days as levels normalize
The guidelines emphasize that high 25OHD concentrations can cause hypercalcemia, hypercalciuria, and if prolonged, nephrocalcinosis and renal failure 1. Research confirms that children with vitamin D intoxication typically present with abdominal pain, vomiting, constipation, and severe hypercalcemia requiring hospitalization 2, 3.
If Normocalcemic (Elevated 25OHD Without Toxicity):
Most patients with very high vitamin D levels remain normocalcemic - one study found 83.7% of patients with 25OHD >88 ng/mL were normocalcemic 4. In this scenario:
- Discontinue all vitamin D supplementation immediately
- Check PTH - expect suppression even without hypercalcemia 4
- Monitor serum calcium weekly for 4 weeks, then monthly until 25OHD normalizes
- Recheck 25OHD in 3 months - the half-life is approximately 10 days initially, but can be prolonged 5
- Avoid calcium-rich foods temporarily (limit dairy, fortified foods)
- Ensure adequate hydration (encourages renal calcium excretion)
Source Investigation
Determine the source of excessive vitamin D intake 2, 3:
- Review ALL supplements, multivitamins, and over-the-counter products
- Check actual vitamin D content - case reports document supplements containing significantly more than labeled amounts 2
- Calculate total daily vitamin D intake from all sources
- Assess for inadvertent overdosing or medication errors
The guidelines note that intoxication is predominantly seen after exposure to high doses of 240,000 to 4,500,000 IU 1, though symptomatic toxicity in RCTs has only been reported at levels ≥500 nmol/L (≥200 ng/mL) 1.
Common Pitfalls to Avoid
- Do not assume toxicity based solely on 25OHD level - calcium status determines clinical significance 1, 4
- Do not restart vitamin D supplementation until 25OHD normalizes to <50 ng/mL
- Do not overlook renal imaging - nephrocalcinosis can develop with prolonged elevation 1, 3
- Do not miss secondary causes - granulomatous diseases can cause elevated 1,25-dihydroxyvitamin D independent of 25OHD
Follow-Up Strategy
- Weekly calcium monitoring for first month if normocalcemic
- Repeat 25OHD at 3 months - expect gradual decline
- Renal ultrasound at 3-6 months if initially abnormal or if hypercalcemia was present
- Resume age-appropriate vitamin D (600 IU/day) only after 25OHD normalizes to <50 ng/mL 1, 6
The key distinction is that while your patient's level is elevated and warrants immediate cessation of supplementation, the presence or absence of hypercalcemia determines whether aggressive treatment is needed versus watchful waiting with close monitoring 1, 4.